Quick Summary
- Serum creatinine is a breakdown product of muscle. The more muscle you carry, the higher your creatinine runs at any given true filtration rate.
- That means creatinine-based eGFR systematically underestimates kidney function in heavily muscled people, and can produce a chronic kidney disease label in someone with normal kidneys.
- Cystatin C is produced by all nucleated cells at a relatively constant rate and is far less influenced by muscle mass, so it is the better second test when creatinine looks bad and nothing else does.
- Discordance between the two estimates is itself informative: large gaps have been associated with worse outcomes in population data, so a mismatch should be investigated rather than dismissed.
- This does not mean muscular athletes never get kidney disease. It means one abnormal creatinine is a reason to test further, not a diagnosis.
Every few weeks someone sends me a lab report with the creatinine flagged red and an estimated GFR that puts them in stage 2 or stage 3 chronic kidney disease, and a note from a physician who has never seen a 240-pound lifter before. Most of the time that person does not have kidney disease. They have muscle. Understanding why requires understanding what creatinine actually is, and it is one of the most useful pieces of lab literacy anyone in this world can acquire.
What Creatinine Actually Measures
Creatine phosphate in skeletal muscle spontaneously and non-enzymatically converts to creatinine at a roughly fixed fractional rate, somewhere near 1.5 to 2 percent of the total muscle creatine pool per day. That creatinine diffuses into blood and is cleared almost entirely by the kidney, primarily by glomerular filtration with a modest contribution from tubular secretion. Because production is relatively constant for a given individual and clearance depends on filtration, the concentration in serum becomes a usable inverse marker of filtration rate.
The phrase doing all the work in that paragraph is for a given individual. Creatinine production is proportional to skeletal muscle mass. Two people with identical, perfectly healthy kidneys will have different serum creatinine concentrations if one carries 30 kilograms of lean mass more than the other. The equations used to convert creatinine into an estimated glomerular filtration rate correct for age and sex, which are crude proxies for body composition, but they do not measure your body composition. They assume you are average. If you have spent a decade making yourself deliberately not average in exactly the tissue that produces the analyte, the estimate breaks.
Baxmann and colleagues demonstrated this directly, showing that serum and urinary creatinine track muscle mass and physical activity while serum cystatin C is comparatively insensitive to both. Dietary intake compounds the problem: cooked meat contains preformed creatinine, and a large steak meal or a heavy creatine supplementation phase can move serum creatinine measurably within a day or two without any change in kidney function whatsoever.
Why Cystatin C Behaves Differently
Cystatin C is a low molecular weight cysteine protease inhibitor produced by essentially all nucleated cells at a fairly steady rate. It is freely filtered at the glomerulus and then almost completely reabsorbed and catabolised by proximal tubular cells, so under normal conditions very little appears in urine. Its serum concentration therefore reflects filtration without being tethered to skeletal muscle mass.
That independence is the entire point. When a lifter presents with a creatinine of 1.4 mg/dL, a cystatin C based estimate frequently lands 20 to 40 percent higher in eGFR terms, and the combined creatinine plus cystatin C equation published by Inker and colleagues in 2021 typically sits between the two. In practice, a cystatin C result that returns a normal estimate in someone whose only abnormality was creatinine is strong evidence that filtration is fine and the creatinine simply reflects the tissue that produced it.
Cystatin C has its own confounders and it is worth knowing them rather than treating it as a perfect test. Thyroid dysfunction moves it in both directions, with hyperthyroidism raising it. Systemic corticosteroids raise it. Marked obesity, active inflammation, and smoking have all been associated with higher values independent of filtration. Some of these are common in this population, so cystatin C is a better test here, not an infallible one.
Discordance Is a Signal, Not Noise
It would be convenient to conclude that muscular athletes should simply ignore creatinine. The data do not support that. Chen and colleagues examined intra-individual differences between creatinine-based and cystatin C-based eGFR and found that large discordance in either direction carried prognostic information, associating with adverse outcomes beyond what either estimate predicted alone. A substantial gap is a finding in its own right.
The practical reading is this. If your creatinine-based eGFR is low and your cystatin C-based eGFR is normal, and your urine albumin-to-creatinine ratio is normal, and your blood pressure is controlled, and imaging is unremarkable, the most likely explanation is body composition. If your creatinine-based eGFR is low and your cystatin C-based eGFR is also low, muscle mass is not your explanation and you need a nephrologist rather than a forum thread.
The Markers That Settle the Question
Filtration estimates are a screening layer. When there is genuine doubt, several cheap tests carry more diagnostic weight than another creatinine draw.
| Test | What it adds | Why it matters here |
|---|---|---|
| Urine albumin-to-creatinine ratio (uACR) | Detects glomerular protein leak long before filtration falls | Normal uACR in the face of a low creatinine-based eGFR argues strongly against meaningful kidney disease. This is arguably the single most informative add-on test. |
| Cystatin C and combined eGFR | Filtration estimate independent of muscle mass | Resolves most false positives created by high lean mass. |
| Urinalysis with microscopy | Blood, casts, protein | Cellular casts or unexplained haematuria change the picture entirely and warrant referral. |
| Renal ultrasound | Structure, obstruction, cyst burden, asymmetry | Cheap, no radiation, rules out structural causes. |
| Blood pressure, repeated and out of office | The dominant modifiable driver of kidney decline | Sustained hypertension damages kidneys silently for years. |
| Serial trend over 6 to 12 months | Trajectory rather than a single point | A stable value for two years is reassuring. A rising slope is the actual warning sign. |
Trajectory deserves emphasis. A single creatinine is a snapshot with meaningful analytical and biological variability layered on top. What you care about is whether filtration is declining over time. Establish a baseline while you are healthy, hydrated, and not in the 48 hours after a brutal training session, and then repeat under similar conditions. Comparing a post-leg-day, dehydrated, high-protein-meal creatinine against one drawn fasted and rested is comparing two different measurements.
Where Enhancement Genuinely Does Damage Kidneys
The muscle-mass explanation is real and it is also the most abused excuse in this space. It is worth being blunt about the mechanisms by which people in this world actually do injure their kidneys, because attributing every abnormal result to lean mass is how someone misses a real problem for three years.
Sustained hypertension is the big one, and androgen use raises blood pressure through several routes including sodium and fluid retention and adverse effects on vascular function. Baggish and colleagues documented meaningful cardiovascular consequences of long-term illicit anabolic-androgenic steroid use, and the kidney sits downstream of the same vasculature. Non-steroidal anti-inflammatory drugs taken habitually for training pain reduce renal perfusion and are a common contributor. Severe rhabdomyolysis from extreme training, stimulant use, or certain drug interactions causes direct tubular injury. Chronic volume depletion from aggressive diuretic use around competition is a recurring cause of acute injury in physique sport. Focal segmental glomerulosclerosis has been reported in a subset of long-term high-dose androgen users with very large lean mass, which is a genuine pathology rather than an artefact.
None of that is a reason to panic about a single creatinine value. It is a reason to take blood pressure seriously, to be honest with a physician about what you are taking, and to actually order the confirmatory tests instead of arguing with the reference range.
How I Frame It
Among the Tony Huge Laws of Biochemistry Physics, this one lands squarely under the chain bottleneck principle: the weakest link determines the output of the system, and your job is to identify which link is actually weak rather than treating the first red flag you see. A flagged creatinine is not the bottleneck. It is a measurement artefact sitting on top of a question you have not answered yet. The answer comes from cystatin C, uACR, blood pressure, and a trend line, and it costs very little to get.
The people who get hurt in this game are rarely the ones who tested and found something. They are the ones who never tested, or who tested once, saw a scary number, decided it was probably just muscle, and never looked again.
Where This Fits in the Bigger Picture
Monitoring is the part of enhancement that nobody posts about, and it is the part that decides how long you get to keep doing this. Testing gives you a feedback loop; without one you are guessing with your organs. Start with the Enhanced Athlete Protocol bloodwork guide, then work through the full protocol hub to see how testing, training, nutrition and recovery connect. If you are early in this, the beginners page is the right entry point.
For related reading, see the hormone optimization pillar on how androgen use interacts with blood pressure and fluid balance, and the recovery pillar on training load and rhabdomyolysis risk.
Frequently Asked Questions
What is cystatin C?
Cystatin C is a small protein produced at a relatively constant rate by all nucleated cells in the body. It is filtered by the kidneys and then reabsorbed and broken down in the proximal tubule, so its concentration in blood reflects glomerular filtration rate. Unlike creatinine, it is not derived from skeletal muscle, which makes it more accurate in people with unusually high or unusually low muscle mass.
Why is my creatinine high if my kidneys are healthy?
Creatinine is produced by the breakdown of creatine phosphate in muscle, so people with large amounts of skeletal muscle produce more of it every day. High protein and cooked meat intake and creatine supplementation add to this. A muscular person with completely normal kidney filtration can therefore run a creatinine that the laboratory reference range flags as abnormal.
Should I stop creatine before a kidney test?
Creatine supplementation modestly raises serum creatinine without harming the kidney. If the goal is a clean baseline, many clinicians suggest pausing supplemental creatine and avoiding large cooked meat meals and intense training for a few days before the draw, and staying well hydrated. Discuss any change with the physician ordering the test, and keep conditions consistent between draws so results are comparable.
Which test is better, cystatin C or creatinine?
Neither is universally better. Cystatin C is more reliable when muscle mass is unusual, which covers most trained athletes. Creatinine is cheaper and more widely available. Current practice increasingly favours measuring both and using the combined equation, because the two together are more accurate than either alone and the size of any disagreement between them is itself clinically informative.
Who should get cystatin C tested?
Anyone whose creatinine-based eGFR looks abnormal but who has no other evidence of kidney disease is a good candidate, and that includes most heavily muscled lifters, as well as people at the opposite extreme such as those with low muscle mass from age or illness. It is also reasonable before starting any medication that requires accurate renal dosing.
References
- Baxmann AC, et al. “Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C.” Clin J Am Soc Nephrol, 2008. doi:10.2215/CJN.02870707 (PMID 18235143)
- Inker LA, et al. “New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.” N Engl J Med, 2021. doi:10.1056/NEJMoa2102953 (PMID 34554658)
- Chen DC, et al. “Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure and Mortality.” Am J Kidney Dis, 2022. doi:10.1053/j.ajkd.2022.05.011 (PMID 35817274)
- Shlipak MG, et al. “Cystatin C versus creatinine for kidney function-based risk.” N Engl J Med, 2013. doi:10.1056/NEJMc1312801 (PMID 24350959)
- Baggish AL, et al. “Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use.” Circulation, 2017. doi:10.1161/CIRCULATIONAHA.116.026945 (PMID 28533317)
- Pettersson J, et al. “Muscular exercise can cause highly pathological liver function tests in healthy men.” Br J Clin Pharmacol, 2008. doi:10.1111/j.1365-2125.2007.03001.x (PMID 17764474)
About Tony Huge
Tony Huge is a self-experimenter, biohacker, and founder of Enhanced Labs. He has spent over a decade researching and personally testing peptides, SARMs, anabolic compounds, nootropics, and longevity protocols. Tony’s mission is to push the boundaries of human potential through science, transparency, and direct experience. Follow his research at tonyhuge.is.